跳至主要内容
临床试验/NCT01075087
NCT01075087已完成不适用

TAP) Block in Morbid Obese Patients Undergoing Laparoscopic Gastric Bypass Surgery: A Prospective,Randomized, Blinded Study

Northwestern University1 个研究点 分布在 1 个国家目标入组 19 人开始时间: 2010年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
19
试验地点
1
主要终点
Quality of Recovery 40 Score

研究概览

简要总结

The use of preoperative TAP block in laparoscopic bariatric surgery can improve the postoperative pain and quality of recovery in patients undergoing these procedures.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age: 18-65 years
  • BMI >35 Kg/m2
  • Surgery: laparoscopic gastric bypass surgery
  • ASA status: I, II and III
  • Fluent in English

排除标准

  • History of allergy to local anesthetics
  • Chronic opioid use
  • Pregnant patients
  • Patients who remained intubated after surgery
  • Drop-out criteria:
  • Patient or surgeon request Complications related to the procedure or conversion to open route Patient requiring mechanical ventilation after surgery

研究组 & 干预措施

Placebo

Placebo Comparator

(control group) will receive sterile normal saline in the block

干预措施: Placebo (Drug)

Active comparator

Active Comparator

(study group) will receive a bilateral TAP block using 20 cc of 0.5% ropivacaine on each side.

干预措施: (study group) will receive a bilateral TAP block using 20 cc of 0.5% ropivacaine on each side. (Drug)

结局指标

主要结局

Quality of Recovery 40 Score

时间窗: 24 hours post operatively

Quality of Recovery 40 Score at 24 hours postoperative.

次要结局

  • 24 Hour Total Opioid Consumption.(24 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Gildasio De Oliveira

Principal Investigator

Northwestern University

研究点 (1)

Loading locations...

相似试验